The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Puthalakath, H., Villunger, A., O'Reilly, L. A., Beaumont, J. G., Coultas, L., Cheney, R. E., Huang, D. C. S., & Strasser, A. (2001) · Science · doi:10.1126/science.1062257 · Cited by 656 · cited 1×
“is sequestered within the actin cytoskelton-based myosin V motor complex; however, Bmf may be released from the complex in response to stressful stimuli, such as detachment of adherent cells from their substratum (anoikis).(41) HtrA2DN induced morphological changes resembling anoikis,(13) which was not suppressed by c…”
Cited by
Reactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
“In addition, Trencia et al. (2004) demonstrated the interaction of antiapoptotic PED/PEA-15 with, and its degradation by, cytosolic HtrA2/OMI.”
BackgroundInfluentialThe inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Circu, M. L., & Yee Aw, T. (2008) · Free Radical Research · doi:10.1080/10715760802317663 · Cited by 393
Cheng, G., Kong, R., Zhang, L., & Zhang, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02025.x · Cited by 343
Recent advances in understanding the cell death pathways activated by anticancer therapy
Kim, R. (2005) · Cancer · doi:10.1002/cncr.20947 · Cited by 314
Madeo, F., Herker, E., Wissing, S., Jungwirth, H., Eisenberg, T., & Fröhlich, K.-U. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.10.012 · Cited by 303
Apoptosome dysfunction in human cancer
Hajra, K. M., & Liu, J. R. (2004) · Apoptosis · doi:10.1023/b:appt.0000045786.98031.1d · Cited by 291
The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer
NACHMIAS, B., ASHHAB, Y., & BENYEHUDA, D. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.002 · Cited by 266
Quality Control of Mitochondrial Proteostasis
Baker, M. J., Tatsuta, T., & Langer, T. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007559 · Cited by 260
Implications of the serine protease HtrA1 in amyloid precursor protein processing
Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., Richards, P., Jones, S. A., Shridhar, V., Clausen, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501823102 · Cited by 215
Omi/HtrA2 Protease Associated Cell Apoptosis Participates in Blood-Brain Barrier Dysfunction
Hu, Y., Bi, Y., Yao, D., Wang, P., & Li, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00048 · Cited by 36
Neel, D. V., Basu, H., Gunner, G., & Chiu, I. M. (2022) · Immunological Reviews · doi:10.1111/imr.13083 · Cited by 22
Metadata
- Authors
- Suzuki, Y., Takahashi-Niki, K., Akagi, T., Hashikawa, T., & Takahashi, R.
- Venue
- Cell Death & Differentiation
- Published
- 2003-11-07
- Volume
- 11
- Issue
- 2
- Pages
- 208-216
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1974129037
- Cited by
- 172
- References
- 3
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.